Primecap Management
SAGE

Primecap Management’s Sage Therapeutics SAGE Stock Holding History

Primecap Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-74,950
Closed -$1.62M – 338
2023
Q4 		$1.62M Sell
74,950
-14,900
-17% -$295K ﹤0.01% 316
2023
Q3 		$1.85M Buy
89,850
+26,250
+41% +$758K ﹤0.01% 305
2023
Q2 		$2.99M Sell
63,600
-2,800
-4% -$139K ﹤0.01% 295
2023
Q1 		$2.79M Buy
66,400
+1,800
+3% +$77.4K ﹤0.01% 295
2022
Q4 		$2.46M Sell
64,600
-13,200
-17% -$504K ﹤0.01% 293
2022
Q3 		$3.05M Hold
77,800
– – ﹤0.01% 292
2022
Q2 		$2.51M Buy
77,800
+9,000
+13% +$302K ﹤0.01% 300
2022
Q1 		$2.28M Buy
68,800
+4,700
+7% +$177K ﹤0.01% 307
2021
Q4 		$2.73M Buy
+64,100
New +$2.68M ﹤0.01% 309

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return